Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03485404Terminated
Randomised, double-blind trial of mecobalamin in Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Xijing Hospital. Primary endpoint: Incidence of Post Operative Cognitive Dysfunction. Started Jan 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03485404.